Celexa, Lexapro Deal Covers Civil Claims Only

By Ben James

Law360, New York (November 09, 2009, 3:18 PM ET) -- Forest Laboratories Inc. and the U.S. Department of Justice have struck a deal to settle civil claims stemming from investigations into the marketing of antidepressants Celexa and Lexapro and a hypothyroidism treatment, but the pact does not cover an ongoing probe into possible criminal violations related to the drugs.

Forest disclosed that it had reached an agreement in principle with the U.S. Attorney's Office for the District of Massachusetts and the DOJ's Civil Division in a quarterly report filed with the Securities and Exchange Commission on...
To view the full article, take a free trial now.

Already a subscriber? Click here to login

You must correct or enter the following before you can submit this form:

All fields required

  5. Required

Only Law360 gives you:

Non-stop coverage of high-stakes litigation across 30 practices

Real-time tracking and reports on 10,000+ companies, firms and industries

Over 80,000 attorney profiles with neutral data collected from active lawsuits

Research tools to find cases, court documents, attorneys and companies

Customized feeds and alerts that can easily be shared with colleagues

In-depth expert analysis from high-profile attorneys at top firms

Access to our vault with over 75,000 original articles